A leading scientific and professional conference bringing together researchers, clinicians, industry leaders, policymakers, and stakeholders to explore the latest advances, challenges, and opportunities in psychedelic drug research and therapeutic development. Topics include clinical trial design, regulatory guidance, drug development strategies, commercialization, legal issues, and emerging clinical data — with ample networking, poster sessions, and panel discussions.
